Top 20 biotech licensing deals in H1 2012

Top 20 biotech licensing deals in H1 2012

Submitted by admin on July 11, 2012 - 12:12pm
Source: 
Fierce Biotech
News Tags: 
Xenon
Virobay
Tolero Pharmaceuticals
Threshold Pharmaceuticals
Novartis
Merck KGaA
Merck
MannKind
licensing
Janssen
Isis Pharmaceuticals
Ironwood
Inhibrx Thrombogenics
GSK
Genmab
Genentech
Galapagos
Forma Therapeutics
Endocyte
Endo
Enanta
Celgene
Bristol-Myers Squibb
Boehringer Ingelheim
Bionomics
Biogen Idec
BioDelivery Sciences
AstraZeneca
Angiochem
AC Immune
Abbott Laboratories
LEO Pharma
Headline: 
Top 20 biotech licensing deals in H1 2012

Do Not Allow Advertisers to Use My Personal information